4.7 Article

Immunoglobulin subtype-coated bacteria are correlated with the disease activity of inflammatory bowel disease

Journal

SCIENTIFIC REPORTS
Volume 11, Issue 1, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41598-021-96289-5

Keywords

-

Funding

  1. Japan Society for the Promotion of Science [15K15284, 17K15914]
  2. Grants-in-Aid for Scientific Research [17K15914, 15K15284] Funding Source: KAKEN

Ask authors/readers for more resources

In inflammatory bowel diseases (IBDs), the presence of Ig-coated bacteria in the intestine is associated with disease activity, with higher percentages of IgA and IgM-coated bacteria in IBD patients. Specific IgG subtypes coating bacteria were only found in IBD patients, and their levels correlated with disease activities in UC and CD patients. This suggests that analyzing Ig-coated bacteria and Ig subtypes using flow cytometry could provide useful indicators of disease activity and potential treatment targets for IBDs.
Immune response involving various immunoglobulin (Ig) isotypes and subtypes to microbiome is involved in the pathogenesis and disease activity of inflammatory bowel diseases (IBDs). To clarify the presence of Ig-coated bacteria in the intestine and its association with disease activity in ulcerative colitis (UC) and Crohn's disease (CD), we extracted and classified Ig-coated bacteria from fecal samples of 42 patients with IBD and 12 healthy controls (HCs) using flow cytometry and 16S ribosomal RNA sequence analysis. The percentage of bacteria coated with IgA and IgM was higher in patients with IBD than in HCs, and IgG-coated bacteria were found only in patients with IBD. Moreover, the percentages of bacteria coated with IgG1, IgG2, IgG3, and IgM in UC samples and IgG3, IgG4, and IgM in CD samples were correlated with disease activities. The proportions of Bacteroides ovatus and Streptococcus increased during the active phase of CD. Hence, the detailed analysis of Ig-coated bacteria and Ig subtypes using flow cytometry could aid in developing useful indicators of disease activity and identifying more disease-related bacteria, which could become novel treatment targets for IBDs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available